AMERICA'S CAR-MART INC (CRMT) Stock Fundamental Analysis
NASDAQ:CRMT - Nasdaq - US03062T1051 - Common Stock - Currency: USD
We assign a fundamental rating of 3 out of 10 to CRMT. CRMT was compared to 120 industry peers in the Specialty Retail industry. CRMT has a bad profitability rating. Also its financial health evaluation is rather negative. CRMT is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
CRMT had positive earnings in the past year.
In the past year CRMT has reported a negative cash flow from operations.
Of the past 5 years CRMT 4 years were profitable.
CRMT had negative operating cash flow in 4 of the past 5 years.
1.2 Ratios
With a Return On Assets value of 0.48%, CRMT perfoms like the industry average, outperforming 50.83% of the companies in the same industry.
The Return On Equity of CRMT (1.38%) is comparable to the rest of the industry.
CRMT has a Return On Invested Capital (4.39%) which is in line with its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CRMT is significantly below the industry average of 13.01%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.48% | ||
| ROE | 1.38% | ||
| ROIC | 4.39% |
ROA(3y)2.51%
ROA(5y)5.59%
ROE(3y)5.78%
ROE(5y)12.01%
ROIC(3y)5.16%
ROIC(5y)8.23%
1.3 Margins
CRMT has a Profit Margin of 0.55%. This is comparable to the rest of the industry: CRMT outperforms 50.83% of its industry peers.
CRMT has a Operating Margin of 5.93%. This is in the better half of the industry: CRMT outperforms 71.67% of its industry peers.
In the last couple of years the Operating Margin of CRMT has declined.
CRMT's Gross Margin of 47.52% is fine compared to the rest of the industry. CRMT outperforms 74.17% of its industry peers.
In the last couple of years the Gross Margin of CRMT has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.93% | ||
| PM (TTM) | 0.55% | ||
| GM | 47.52% |
OM growth 3Y-50.98%
OM growth 5Y-28.87%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.24%
GM growth 5Y-1.28%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CRMT is destroying value.
The number of shares outstanding for CRMT remains at a similar level compared to 1 year ago.
The number of shares outstanding for CRMT has been reduced compared to 5 years ago.
CRMT has a worse debt/assets ratio than last year.
2.2 Solvency
CRMT has an Altman-Z score of 1.89. This is not the best score and indicates that CRMT is in the grey zone with still only limited risk for bankruptcy at the moment.
CRMT has a Altman-Z score (1.89) which is comparable to the rest of the industry.
CRMT has a Debt/Equity ratio of 1.43. This is a high value indicating a heavy dependency on external financing.
CRMT has a worse Debt to Equity ratio (1.43) than 64.17% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.43 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.89 |
ROIC/WACC0.41
WACC10.63%
2.3 Liquidity
A Current Ratio of 1.56 indicates that CRMT should not have too much problems paying its short term obligations.
CRMT has a Current ratio of 1.56. This is in the better half of the industry: CRMT outperforms 65.00% of its industry peers.
A Quick Ratio of 0.42 indicates that CRMT may have some problems paying its short term obligations.
The Quick ratio of CRMT (0.42) is worse than 60.83% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.56 | ||
| Quick Ratio | 0.42 |
3. Growth
3.1 Past
CRMT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 100.85%, which is quite impressive.
Looking at the last year, CRMT shows a decrease in Revenue. The Revenue has decreased by -2.26% in the last year.
Measured over the past years, CRMT shows a quite strong growth in Revenue. The Revenue has been growing by 15.81% on average per year.
EPS 1Y (TTM)100.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%127.61%
Revenue 1Y (TTM)-2.26%
Revenue growth 3Y15.29%
Revenue growth 5Y15.81%
Sales Q2Q%8.72%
3.2 Future
The Earnings Per Share is expected to grow by 47.57% on average over the next years. This is a very strong growth
CRMT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.67% yearly.
EPS Next Y131.73%
EPS Next 2Y66.49%
EPS Next 3Y47.57%
EPS Next 5YN/A
Revenue Next Year-2.17%
Revenue Next 2Y1.54%
Revenue Next 3Y4.67%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 1244.00, CRMT can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of CRMT indicates a slightly more expensive valuation: CRMT is more expensive than 60.83% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 26.25. CRMT is valued rather expensively when compared to this.
With a Price/Forward Earnings ratio of 13.02, CRMT is valued correctly.
Based on the Price/Forward Earnings ratio, CRMT is valued a bit cheaper than the industry average as 71.67% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.15, CRMT is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 1244 | ||
| Fwd PE | 13.02 |
4.2 Price Multiples
CRMT's Enterprise Value to EBITDA ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 13.18 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CRMT does not grow enough to justify the current Price/Earnings ratio.
CRMT's earnings are expected to grow with 47.57% in the coming years. This may justify a more expensive valuation.
PEG (NY)9.44
PEG (5Y)N/A
EPS Next 2Y66.49%
EPS Next 3Y47.57%
5. Dividend
5.1 Amount
No dividends for CRMT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
49.76
+2.03 (+4.25%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)
Earnings (Next)
Inst Owners87.84%
Inst Owner Change3.72%
Ins Owners10.49%
Ins Owner Change0.55%
Market Cap411.02M
Analysts51.11
Price Target51.77 (4.04%)
Short Float %14.29%
Short Ratio11.05
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0.01
Dividend Growth(5Y)1.32%
DP0.52%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)44.84%
Min EPS beat(2)-140.1%
Max EPS beat(2)229.77%
EPS beat(4)1
Avg EPS beat(4)-31.47%
Min EPS beat(4)-140.1%
Max EPS beat(4)229.77%
EPS beat(8)1
Avg EPS beat(8)-121.19%
EPS beat(12)2
Avg EPS beat(12)-92.73%
EPS beat(16)5
Avg EPS beat(16)-62.37%
Revenue beat(2)2
Avg Revenue beat(2)4.39%
Min Revenue beat(2)0.63%
Max Revenue beat(2)8.15%
Revenue beat(4)3
Avg Revenue beat(4)2.08%
Min Revenue beat(4)-1.09%
Max Revenue beat(4)8.15%
Revenue beat(8)5
Avg Revenue beat(8)-0.02%
Revenue beat(12)8
Avg Revenue beat(12)1.72%
Revenue beat(16)12
Avg Revenue beat(16)3.84%
PT rev (1m)-2.4%
PT rev (3m)-2.4%
EPS NQ rev (1m)-13.6%
EPS NQ rev (3m)0.7%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.95%
Revenue NQ rev (1m)-4.85%
Revenue NQ rev (3m)-0.98%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.2%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 1244 | ||
| Fwd PE | 13.02 | ||
| P/S | 0.3 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.74 | ||
| P/tB | 0.77 | ||
| EV/EBITDA | 13.18 |
EPS(TTM)0.04
EY0.08%
EPS(NY)3.82
Fwd EY7.68%
FCF(TTM)-10.06
FCFYN/A
OCF(TTM)-9.53
OCFYN/A
SpS167.73
BVpS67.58
TBVpS64.82
PEG (NY)9.44
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.48% | ||
| ROE | 1.38% | ||
| ROCE | 5.55% | ||
| ROIC | 4.39% | ||
| ROICexc | 4.41% | ||
| ROICexgc | 4.48% | ||
| OM | 5.93% | ||
| PM (TTM) | 0.55% | ||
| GM | 47.52% | ||
| FCFM | N/A |
ROA(3y)2.51%
ROA(5y)5.59%
ROE(3y)5.78%
ROE(5y)12.01%
ROIC(3y)5.16%
ROIC(5y)8.23%
ROICexc(3y)5.19%
ROICexc(5y)8.49%
ROICexgc(3y)5.24%
ROICexgc(5y)8.58%
ROCE(3y)6.52%
ROCE(5y)10.42%
ROICexcg growth 3Y-54.52%
ROICexcg growth 5Y-33.5%
ROICexc growth 3Y-54.52%
ROICexc growth 5Y-33.63%
OM growth 3Y-50.98%
OM growth 5Y-28.87%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.24%
GM growth 5Y-1.28%
F-Score5
Asset Turnover0.86
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.43 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 8.89 | ||
| Cap/Depr | 58.51% | ||
| Cap/Sales | 0.32% | ||
| Interest Coverage | 1.06 | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.56 | ||
| Quick Ratio | 0.42 | ||
| Altman-Z | 1.89 |
F-Score5
WACC10.63%
ROIC/WACC0.41
Cap/Depr(3y)292.11%
Cap/Depr(5y)251.61%
Cap/Sales(3y)1.11%
Cap/Sales(5y)1.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)100.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%127.61%
EPS Next Y131.73%
EPS Next 2Y66.49%
EPS Next 3Y47.57%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.26%
Revenue growth 3Y15.29%
Revenue growth 5Y15.81%
Sales Q2Q%8.72%
Revenue Next Year-2.17%
Revenue Next 2Y1.54%
Revenue Next 3Y4.67%
Revenue Next 5YN/A
EBIT growth 1Y267.14%
EBIT growth 3Y-43.48%
EBIT growth 5Y-17.62%
EBIT Next Year346.24%
EBIT Next 3Y79.21%
EBIT Next 5YN/A
FCF growth 1Y49.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y43.72%
OCF growth 3YN/A
OCF growth 5YN/A